Cambridge's cancer drug spinout Storm Therapeutics convinced its existing investors to join new participant Seroba Life Sciences for a second extension that brought its series A total to $38.2m.

The SoftBank-backed food delivery platform is reportedly seeking a minimum of $500m at a valuation of about $13bn.

Power Corporation's Portag3 Ventures unit led a $32.1m round for the digital bank operator, which will use the funds to expand its app-based service.

HCSC Ventures led the disease prevention platform's series C round, investing alongside Blue Cross Blue Shield Venture Partners.

Illumina Ventures and M Ventures made follow-on investments in synthetic DNA platform developer DNA Script as part of its $38.5m series B round.

Mahindra's private equity unit invested $29.3m in the ophthalmology centre operator, in a deal that enabled Matrix Partners India to exit.

Sector analysis: Media

Keith Cowan, previously president of Sprint, has taken the place of Mark Kaiser as chief executive at corporate venturing services provider Venadar, where he was already chairman.

Monthly analysis: April 2019

Finarya is lining up funding from state-run bank BRI's corporate venturing unit, which is taking a 19% stake in the Mobile wallet provider.